Today’s shoppers want products delivered quickly. Local businesses are positioned to fill that demand, if only USPS’s Louis DeJoy would notice.
Political Animal
Trump Praises the Capitol Insurrection. Will the GOP Dare to Follow?
Trump is praising the mob and turning insurrectionist Ashli Babbitt into a martyr. This is not going to help Republicans in the midterm elections.
Assassination of Haitian Leader Highlights Nation’s Monopoly-Dominated Economy
The killing of President Jovenal Moïse took place against a backdrop of elite power, anticompetitive policies, and the U.S. doing little to create open markets.
The FDA Is Broken
How the Food and Drug Administration messes up approval of new drugs including the new one, aducanumab, that supposedly helps Alzheimer’s disease patients.
I’m a Biased Journalist and I’m Okay With That
Being fair and having a point of view aren’t incompatible. Reporters at the New York Times and elsewhere shouldn’t have to disguise or suppress their views.
No, School Board Fights Over Critical Race Theory Are Not Going to Hurt Democrats
In red-turned-blue Loudoun County, Virginia a fight over how to teach students about America’s racial history has animated Fox News and conservatives. But it’s faux outrage.
The Unemployed Elderly Are a Dangerous Political Force. Here’s Why.
The political war we expected between old and young is not the one we got.
What New York City Taught Us About Ranked Choice Voting and the Democratic Party
The Eric Adams victory has lessons for how candidates can win under the system. Hint: Running in tandem with others is overrated.
The Hardball Way to Push Republicans to Vote for Infrastructure
Democrats have to get tougher by sounding the alarm about collapsing bridges and dangerous roads in each GOP district and state.
That Wildly Expensive New Alzheimer’s Drug Needs Serious Testing
Why Biogen’s medication, aducanumab, should get studied through an important part of the Affordable Care Act, the Patient Centers Outcomes Research Institute.

